A major pharmaceutical company ended price hikes and monopoly protection over a life-saving asthma inhaler following two years of pressure from U.S. Sen. Maggie Hassan, D-N.H. Without warning in ...
Glaxo Smith Kline’s decision to discontinue a popular children’s asthma inhaler, Flovent, more than two years ago has caused ...
Robust real-world data on the effectiveness of biologic therapies in children with severe asthma remain limited, particularly ...
Life as a teenager and older adolescent is defined by turbulence. Normal body changes and hormonal shifts cause emotional and social challenges. As high school ends and adulthood begins, this ...
Please provide your email address to receive an email when new articles are posted on . Families used an app at least once a month to report asthma symptoms or track lung function. The proportion of ...
One out of every 12 school-age children has asthma, which is the most common reason for missed school days. Any time a child develops asthma symptoms, it’s worth looking at what they ate, touched, or ...
A major pharmaceutical company ended price hikes and monopoly protection over a life-saving asthma inhaler following two years of pressure from U.S. Sen. Maggie Hassan, D-N.H. Without warning in ...
The change will make asthma infusion treatments a pharmacy benefit, meaning policyholders will have to self-inject these four asthma infusion medications. Mykal McEldowney/IndyStar USA TODAY NETWORK A ...
Starting this April, the biggest health insurer in Texas plans to restrict treatment options for patients suffering from severe asthma. Blue Cross Blue Shield — which covers more than 10 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results